drugset / Trial / NCT02218034
Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris
RandomizedParallel-groupSingle-blindBasic science
Summary
This is a safety, tolerability and pharmacokinetics study of AGN-190168 in subjects with acne vulgaris.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGN-190168 Formulation 1 | Unknown | — | Topical |
| Subject | AGN-190168 Formulation 2 | Unknown | — | Topical |
| Comparator | Tazarotene | Small molecule | 0.1 % | Topical |